eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2018
vol. 35
 
Share:
Share:
more
 
 
abstract:
Review paper

Craniofacial and cutaneous findings in Noonan, Costello and LEOPARD syndromes

Rafał Pokrowiecki, Piotr Chomik, Maciej Borowiec, Krzysztof Dowgierd, Anna Starzyńska

Adv Dermatol Allergol 2018; XXXV (5): 437-441
Online publish date: 2018/07/19
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Noonan, Costello and LEOPARD syndromes belong to a family of cardiofaciocutaneous disorders and share common genetic traits. As they are associated with a germline mutation in genes encoding proteins involved in RAS/MAPK, patients suffering from these syndromes are at a greater risk of cancer and abnormal myelopoiesis in infancy. Patients with cardio faciocutaneous syndromes share some clinically overlapping syndromes, therefore differential diagnosis can be problematic. In this paper we aim at demonstrating distinctive craniofacial and cutaneous manifestations of Noonan, Costello and LEOPARD syndromes which can be useful for clinicians who aim at treatment of children with rare diseases.
keywords:

Noonan, Costello, LEOPARD, craniofacial, cutaneous

references:
Smithson SF, Winter RM. Diagnosis in dysmorphology: clues from the skin. Br J Dermatol 2004; 151: 953-60.
Bessis D. Neuro-cardio-facial-cutaneous syndrome. Ann Dermatol Vénéréol 2011; 138: 483-93.
Denayer E, Legius E. What’s new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr 2007; 166: 1091-8.
Cizmarova M, Kostalova L, Pribilincova Z, et al. Rasopathies – dysmorphic syndromes with short stature and risk of malignancy. Endocr Regul 2013; 47: 217-22.
Niemeyer CM. RAS diseases in children. Haematologica 2014; 99: 1653-62.
Agarwal P, Philip R, Gutch M, et al. The other side of Turner’s: Noonan’s syndrome. Indian J Endocrinol Metab 2013; 17: 794-8.
Neumann TE, Allanson J, Kavamura I, et al. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome. Eur J Hum Genet 2009; 17: 420-5.
Jongmans MCJ, van der Burgt I, Hoogerbrugge PM, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet 2011; 19: 870-4.
Roberts AE, Allanson JE, Tartaglia M, et al. Noonan syndrome. Lancet 2013; 381: 333-42.
Allanson JE. Noonan syndrome. J Med Genet 1987; 24: 9-13.
Addissie YA, Kotecha U, Hart RA, et al. Craniosynostosis and Noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature. Am J Med Genet A 2015; 167: 2657-63.
Lee NB, Kelly L, Sharland M. Ocular manifestations of Noonan syndrome. Eye 1992; 6: 328-34.
Noonan JA. Noonan syndrome and related disorders. Prog Pediatr Cardiol 2005; 20: 177-85.
Allanson JE, Bohring A, Dörr HG, et al. The face of Noonan syndrome: does phenotype predict genotype. Am J Med Genet A 2010; 152A: 1960-6.
Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 2010; 126: 746-59.
Digilio M, Marino B. Clinical manifestations of Noonan syndrome. Images Paediatr Cardiol 2001; 3: 19-30.
Khirani S, Leboulanger N, Ramirez A, et al. Life-threatening obstructive sleep apnea caused by adenoid hypertrophy in an infant with Noonan syndrome. Case Rep Pediatr 2012; 2012: 514514.
Allanson JE, Hall JG, Hughes HE, et al. Noonan syndrome: the changing phenotype. Am J Med Genet 1985; 21: 507-14.
Bhambhani V, Muenke M. Noonan syndrome. Am Fam Physician 2014; 89: 37-43.
Cardiel Ríos SA. Correction of a severe class II malocclusion in a patient with Noonan syndrome. Am J Orthod Dentofacial Orthop 2016; 150: 511-20.
Quaio C, Almeida T, Brasil A, et al. Tegumentary manifestations of Noonan and Noonan-related syndromes. Clinics 2013; 68: 1079-83.
Wolvius EB, de Lange J, Smeets EEJ, et al. Noonan-like/multiple giant cell lesion syndrome: report of a case and review of the literature. J Oral Maxillofac Surg 2006; 64: 1289-92.
Bufalino A, Carrera M, Carlos R, et al. Giant cell lesions in noonan syndrome: case report and review of the literature. Head Neck Pathol 2010; 4: 174-7.
van den Berg H, Schreuder WH, Jongmans M, et al. Multiple giant cell lesions in a patient with Noonan syndrome with multiple lentigines. Eur J Med Genet 2016; 59: 425-8.
Ueno T, Miyamoto JJ, Kataoka K, et al. An investigation of maxillofacial morphology and oral characteristic in patients with Noonan syndrome. Orthod Waves 2016; 75: 24-5.
Farias Lemos C, Duarte Caldas L, Ferreira Brasileiro B, et al. Dentofacial changes of Noonan syndrome: report of two clinical cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117: e152.
Sugar AW, Ezsias A, Bloom AL, et al. Orthognathic surgery in a patient with Noonan’s syndrome. J Oral Maxillofac Surg 1994; 52: 421-5.
Urs P, Konde S, Chouta N, et al. LEOPARD syndrome: you could be the first one to diagnose! J Indian Soc Pedod Prev Dent 2015; 33: 57-60.
Yam AA, Faye M, Kane A, et al. Oro-dental and craniofacial anomalies in LEOPARD syndrome. Oral Dis 2001; 7: 200-2.
Coppin BD, Temple IK. Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis). J Med Genet 1997; 34: 582-6.
Chong WS, Klanwarin W, Giam YC. Generalized lentiginosis in two children lacking systemic associations: case report and review of the literature. Pediatr Dermatol 2004; 21: 139-45.
Bujaldón AR. LEOPARD syndrome: what are café noir spots? Pediatr Dermatol 2008; 25: 444-8.
Lenane P, Powell FC. Oral pigmentation. J Eur Acad Dermatology Venereol 2000; 14: 448-65.
Aoki Y, Niihori T, Inoue SI, et al. Recent advances in RASopathies. J Hum Genet 2016; 61: 33-9.
Digilio MC, Conti E, Sarkozy A, et al. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 2002; 71: 389-94.
Yanase S, Nomura J, Yamamoto W, et al. A case of Costello syndrome with delayed eruption of primary teeth. Asian
J Oral Maxillofac Surg 2013; 25: 267-70.
Takahashi M, Ohashi H. Craniofacial and dental malformations in Costello syndrome: a detailed evaluation using multi-detector row computed tomography. Congenit Anom (Kyoto) 2013; 53: 67-72.
Gripp KW, Scott CI, Nicholson L, et al. Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. Am J Med Genet 2002; 108: 80-7.
Johnson JP, Golabi M, Norton ME, et al. Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause. J Pediatr 1998; 133: 441-8.
Hennekam RCM. Costello syndrome: an overview. Am J Med Genet 2003; 117C: 42-8.
Costello JM. Costello syndrome: update on the original cases and commentary. Am J Med Genet 1996; 62: 199-201.
Allanson JE. Objective studies of the face of noonan, cardio-facio-cutaneous, and Costello syndromes: a comparison of three disorders of the Ras/MAPK signaling pathway. Am J Med Genet Part A 2016; 170: 2570-7.
Lorenz S, Petersen C, Kordaß U, et al. Two cases with severe lethal course of Costello syndrome associated with HRAS p.G12C and p.G12D. Eur J Med Genet 2012; 55: 615-9.
Gripp KW, Lin AE. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med 2012; 14: 285-92.
Lin A, Harding C, Silberbach M. Insights hand it to the skin in Costello syndrome. J Pediatr 2004; 144: 135.
Dileone M, Zampino G, Profice P, et al. Dystonia in Costello syndrome. Park Relat Disord 2012; 18: 798-800.
Siegel DH, Mann JA, Krol AL, et al. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development. Br J Dermatol 2012; 166: 601-7.
White SM, Graham JM, Kerr B, et al. The adult phenotype in Costello syndrome. Am J Med Genet Part A 2005; 136A: 128-35.
Nguyen V, Buka RL, Roberts BJ, et al. Cutaneous manifestations of Costello syndrome. Int J Dermatol 2007; 46: 72-6.
Adigun CG, Pandya AG. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. J Eur Acad Dermatol Venereol 2009; 23: 486-7.
Torrelo A, López-Avila A, Mediero IG, et al. Costello syndrome. J Am Acad Dermatol 1995; 32: 904-7.
Mori M, Yamagata T, Mori Y, et al. Elastic fiber degeneration in Costello syndrome. Am J Med Genet 1996; 61: 304-9.
Umans S, Decock P, Fryns JP. Costello syndrome: the natural history of a true postnatal growth retardation syndrome. Genet Couns 1995; 6: 121-5.
Della Marca G, Vasta I, Scarano E, et al. Obstructive sleep apnea in Costello syndrome. Am J Med Genet A 2006; 140: 257-62.
Di Rocco M, Gatti R, Gandullia P, et al. Report on two patients with Costello syndrome and sialuria. Am J Med Genet 1993; 47: 1135-40.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe